Predictors of Cognitive Impairments and Mood Disorders after Subthalamic Deep Brain Stimulation in Patients with Parkinson’s Disease
Objective: We aimed to determine the predictors of cognitive decline and mood disorders after STN-DBS in PD. Background: Cognitive impairment and mood disorders are the…Inpatient Multimodal Care Improves Parkinsonian Symptoms Regardless Of Race Or Ethnicity
Objective: To verify demographic characteristics of patients with Parkinson’s disease (PD) completing a two-week inpatient multimodal intensive neurorehabilitation and care (iMINC) program and whether iMINC…Basal Ganglia Neurophysiological Activity Associated with Depression in Parkinson’s Disease
Objective: The objective of this study was to identify neurophysiological activity in the basal ganglia associated with depression in patients with Parkinson’s disease (PD) undergoing…Neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy in reference centers of Valle del Cauca- Colombia
Objective: To evaluate the neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy attended in reference centers of the Valle del Cauca, Colombia, between 2020 and…Apathy in de novo Parkinson’s disease improves after the first years with dopaminergic treatment.
Objective: to define the evolution of apathy and other neuropsychiatric symptoms in patients with early Parkinson’s disease (PD). Background: Apathy is a common neuropsychiatric symptom…Measuring Cortisol Levels in Persons with Huntington’s Disease
Objective: To assess subjective and objective measures of emotional stress via standardized scales and a physiological measure (salivary cortisol) in persons with Huntington’s Disease (HD)…The Clinical Landscape of Progressive Supranuclear Palsy in an Underserved Community from Southwestern Colombia
Objective: To elucidate the clinical presentation of Progressive Supranuclear Palsy (PSP) in a cohort residing in underserved communities in Buenaventura, Colombia—the country's primary maritime port…Characterizing Dopaminergic Correlates of Depression in Parkinson’s Disease: The PPMI Cohort
Objective: We explored the association between cerebrospinal fluid (CSF) dopamine metabolites and transporter denervation in the development of depression in Parkinson Disease (PD). Background: Depression…Validation of a New Patient-reported Outcome Scale for the Assessment of Essential Tremor
Objective: Develop and validate a TETRAS PRO subscale Background: The Essential Tremor Rating Assessment Scale (TETRAS) is a popular scale for essential tremor (ET), but…The assessment of anxiety and depression comorbidities and the DRN electrophysiology in a primate model of Parkinson’s Disease
Objective: The study aimed to examine the anxiety/depression-like phenotype and the potential role of dorsal raphe nucleus (DRN) in the gold standard primate model of…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 36
- Next Page »